Compare ALGN & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALGN | CFR |
|---|---|---|
| Founded | 1997 | 1868 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3B | 10.2B |
| IPO Year | 2000 | 1994 |
| Metric | ALGN | CFR |
|---|---|---|
| Price | $145.53 | $153.08 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 15 |
| Target Price | ★ $206.36 | $173.79 |
| AVG Volume (30 Days) | ★ 752.2K | 398.1K |
| Earning Date | 10-28-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 2.70% |
| EPS Growth | 0.53 | ★ 11.84 |
| EPS | 3.09 | ★ 5.35 |
| Revenue | $387,126,000.00 | ★ $2,235,244,000.00 |
| Revenue This Year | $3.22 | $3.80 |
| Revenue Next Year | $4.07 | $6.40 |
| P/E Ratio | $46.46 | ★ $28.82 |
| Revenue Growth | ★ 23.95 | 8.31 |
| 52 Week Low | $124.91 | $119.00 |
| 52 Week High | $200.44 | $170.80 |
| Indicator | ALGN | CFR |
|---|---|---|
| Relative Strength Index (RSI) | 38.25 | 29.63 |
| Support Level | N/A | $133.49 |
| Resistance Level | $154.10 | $170.55 |
| Average True Range (ATR) | 4.09 | 2.84 |
| MACD | 0.15 | -0.76 |
| Stochastic Oscillator | 22.05 | 0.98 |
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Cullen/Frost is a regional US bank with around $54 billion in assets (as of June 2026), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based banking approach that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through targeted branch openings rather than acquisitions. The bank's sweet spot is small to medium-sized Texas-based commercial clients.